KAVISH PATIDAR to End Stage Liver Disease
This is a "connection" page, showing publications KAVISH PATIDAR has written about End Stage Liver Disease.
Connection Strength
3.307
-
Clinical characteristics and prognosis of hospitalized patients with moderate alcohol-associated hepatitis. Liver Int. 2024 01; 44(1):241-249.
Score: 0.729
-
Severe Alcohol-Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure. Hepatol Commun. 2022 05; 6(5):1090-1099.
Score: 0.639
-
Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury. Liver Int. 2022 01; 42(1):187-198.
Score: 0.638
-
Controversies in terlipressin and transplantation in the United States: How do we MELD the two? Liver Transpl. 2024 Jul 01; 30(7):753-759.
Score: 0.188
-
Optimization of Kidney Health in Liver Transplant Candidates: Pretransplant Considerations and Modalities. Transplantation. 2024 07 01; 108(7):1542-1550.
Score: 0.185
-
PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver disease. Hepatology. 2023 12 01; 78(6):1788-1799.
Score: 0.177
-
Measuring Medication Use, Obstacles, and Knowledge in Individuals With Cirrhosis. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1819-1830.e5.
Score: 0.168
-
Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1426-e1437.
Score: 0.156
-
Comorbidity Burden May Be Associated with Increased Mortality in Patients with Severe Acute Liver Injury Referred for Liver Transplantation. Ann Transplant. 2020 Nov 03; 25:e926453.
Score: 0.148
-
Admission plasma uromodulin and the risk of acute kidney injury in hospitalized patients with cirrhosis: a pilot study. Am J Physiol Gastrointest Liver Physiol. 2019 10 01; 317(4):G447-G452.
Score: 0.136
-
Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: Results from the HRS-HARMONY consortium. Liver Transpl. 2024 Nov 01; 30(11):1106-1115.
Score: 0.048
-
Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosis. Liver Transpl. 2025 Jan 01; 31(1):24-31.
Score: 0.048
-
Performance of race-neutral eGFR equations in patients with decompensated cirrhosis. Liver Transpl. 2025 Feb 01; 31(2):170-180.
Score: 0.047